Current Report Filing (8-k)
August 24 2016 - 5:23PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 24, 2016
CytoDyn Inc.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-49908
|
|
75-3056237
|
(State or other jurisdiction
of incorporation)
|
|
(SEC
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
1111 Main Street, Suite 660
Vancouver, Washington
|
|
98660
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (360) 980-8524
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.03
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
|
On August 24,
2016, CytoDyn Inc. (the
Company
) filed with the Secretary of State of Delaware a Certificate of Amendment (the
Certificate of Amendment
) to its Certificate of Incorporation (the
Certificate of
Incorporation
), increasing the number of authorized shares of common stock of the Company from 250,000,000 to 350,000,000 shares. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and incorporated by reference
herein. The Companys shareholders approved the Certificate of Amendment at an annual meeting of the shareholders on August 24, 2016 (the
Annual Meeting
), as more specifically described under Item 5.07 below.
Item 5.07
|
Submission of Matters to a Vote of Security Holders
.
|
The final results for each of the matters
submitted to a vote of shareholders at the Annual Meeting are set forth below. A more detailed description of each proposal is set forth in the Companys Proxy Statement filed with the Securities and Exchange Commission on July 20, 2016.
Proposal No. 1 Election of seven directors
. The stockholders elected seven directors, each for a one-year term:
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominee
|
|
Shares
Voted For
|
|
|
Shares
Withheld
|
|
|
Broker Non-
Votes
|
|
Nader Z. Pourhassan, Ph.D.
|
|
|
63,200,530
|
|
|
|
4,199,738
|
|
|
|
17,235,067
|
|
Denis R. Burger, Ph.D.
|
|
|
63,788,462
|
|
|
|
3,611,806
|
|
|
|
17,235,067
|
|
Anthony D. Caracciolo
|
|
|
63,414,946
|
|
|
|
3,985,322
|
|
|
|
17,235,067
|
|
Carl C. Dockery
|
|
|
63,533,853
|
|
|
|
3,866,415
|
|
|
|
17,235,067
|
|
Gregory A. Gould
|
|
|
63,406,946
|
|
|
|
3,993,322
|
|
|
|
17,235,067
|
|
A. Bruce Montgomery, M.D.
|
|
|
63,562,945
|
|
|
|
3,837,323
|
|
|
|
17,235,067
|
|
Jordan G. Naydenov
|
|
|
63,461,853
|
|
|
|
3,938,415
|
|
|
|
17,235,067
|
|
Proposal No. 2 Amendment to Certificate of Incorporation to Increase the Number of Authorized Shares
. The
stockholders approved a proposal to amend the Certificate of Incorporation to increase the total number of authorized shares of common stock of the Company from 250,000,000 to 350,000,000 by the votes set forth in the table below:
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstained
|
|
Broker Non-Vote
|
71,888,688
|
|
12,476,859
|
|
269,788
|
|
0
|
Proposal No. 3 Approval of Reverse Stock Split
. The stockholders approved a proposal to effect a reverse
stock split at a ratio of any whole number between one-for-two and one-for-eight, as determined by the board of directors, at any time before August 24, 2017, if and as determined by the Companys board of directors.
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstained
|
|
Broker Non-Vote
|
68,419,004
|
|
15,599,929
|
|
616,402
|
|
0
|
Proposal No. 4 Ratification of Selection of Independent Registered Public Accounting Firm.
The stockholders
approved to select Warren Averett, LLC as the Companys independent registered public accounting firm to examine the financial statements of the Company for the fiscal year ending May 31, 2017.
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstained
|
|
Broker Non-Vote
|
82,976,003
|
|
1,514,911
|
|
144,421
|
|
0
|
Proposal No. 5 Advisory Vote on Executive Compensation.
The stockholders approved the
compensation paid to the Companys executive officers.
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstained
|
|
Broker Non-Vote
|
51,389,460
|
|
9,640,022
|
|
6,370,786
|
|
17,235,067
|
Item 9.01
|
Financial Statements and Exhibits
.
|
(d)
|
Exhibits. The following exhibits are filed herewith:
|
|
|
|
Exhibit
No.
|
|
Description
|
|
|
3.1
|
|
Certificate of Amendment to the Certificate of Incorporation of CytoDyn Inc.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CytoDyn Inc.
|
|
|
|
|
August 24, 2016
|
|
|
|
By:
|
|
/s/ Michael D. Mulholland
|
|
|
|
|
Name:
|
|
Michael D. Mulholland
|
|
|
|
|
Title:
|
|
Chief Financial Officer
|
Exhibit Index
|
|
|
Exhibit
No.
|
|
Description
|
|
|
3.1
|
|
Certificate of Amendment to the Certificate of Incorporation of CytoDyn Inc.
|
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Mar 2024 to Apr 2024
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Apr 2023 to Apr 2024